基本资料 投资组合 财务数据 基金公告
标普生物科技LOF(161127) |
净值：
2.1103
|
日增长率：
1.72%
|
累计净值：2.1103 | 2026-06-29 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| APLS | Apellis Pharmaceuticals Inc | 22,686.00 | 6,315,044.24 | 1.75 |
| ALKS | 阿尔凯默斯 | 20,417.00 | 4,995,427.06 | 1.38 |
| MDGL | Madrigal Pharmaceuticals Inc | 1,314.00 | 4,759,437.19 | 1.32 |
| TGTX | TG Therapeutics Inc | 20,214.00 | 4,646,439.93 | 1.29 |
| INSM | Insmed Inc | 4,068.00 | 4,602,780.45 | 1.27 |
| SRRK | Scholar Rock Holding Corp | 13,131.00 | 4,466,610.81 | 1.24 |
| APGE | Apogee Therapeutics Inc | 7,593.00 | 4,422,207.98 | 1.22 |
| PTGX | Protagonist Therapeutics Inc | 5,877.00 | 4,286,124.07 | 1.19 |
| SMMT | Summit Therapeutics Inc | 32,567.00 | 4,272,524.13 | 1.18 |
| UTHR | 联合治疗 | 1,041.00 | 4,271,291.51 | 1.18 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-03-31 | 95.11 | - | 6.48 | 361,394,474.46 |
| 2025-12-31 | 93.31 | - | 6.89 | 540,570,944.34 |
| 2025-09-30 | 94.77 | - | 6.01 | 444,884,437.23 |
| 2025-06-30 | 94.45 | - | 5.85 | 333,553,426.09 |
| 2025-03-31 | 94.28 | - | 6.80 | 296,810,618.81 |
| 起始日 | 截止日 | 基金经理 | 任职天数 | 任期回报率% |
| 2021-04-15 | - | 宋钊贤 | 1904 | 18.21 |
| 2023-02-10 | 2024-07-13 | 庞亚平 | 519 | 18.82 |
| 2018-08-11 | 2020-04-23 | 刘树荣 | 621 | -0.80 |
| 2017-03-25 | 2021-04-15 | FAN BING(范冰) | 1482 | 67.25 |
| 2016-12-15 | 2018-08-11 | 张胜记 | 604 | 41.52 |
| 2016-12-13 | 2018-08-11 | 林伟斌 | 606 | 41.52 |
微信公众号
证券之星APP
